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1, Introduction 
The neurones, containing dopamine, which originate 
in the substantia nigra (SN) and project in the striatum 
constitute the nigro-striatal dopaminergic pathway. The 
dopamine (DA) released from the dopaminergic nerve 
terminals interacts with a postsynaptic dopaminergic 
receptor which is coupled with a specific dopamine 
sensitive adenylate cyclase [l-6] . This adenylate 
cyclase has a topographical distribution similar to that 
of dopaminergic terminals [6,7] and remains after 
degeneration of the dopaminergic nigro-striatal path- 
way. From pharmacological data, it has been proposed 
that dopaminergic terminals in the striatum possessed 
another categoric of dopaminergic receptors also 
called ‘autoreceptors’ [8] since they are sensitive to 
the neurotransmitter of the neurone on which they are 
localized. They are involved in the control of dop- 
amine synthesis [8] and release [9,10]. These auto- 
receptors are widely distributed in all the different parts 
of the dopaminergic neurones and especially on the 
cell bodies in the substantia nigra [ 1 l-l 41. 
The present study was done in order to know if the 
autoreceptors of the substantia nigra are coupled with 
an adenylate cyclase in the same way as the striatal 
postsynaptic dopaminergic receptors. For this purpose, 
the substantia nigra was dissected on frozen slices 
(-7°C) and homogenates prepared: they were found 
to contain a dopamine sensitive adenylate cyclase. 
This adenylate cyclase was also stimulated by Lnore- 
pinephrine and to a lesser extent by apomorphine. 
Various neuroleptics which blocked the striatal dop- 
amine sensitive adenylate cyclase were also able to 
inhibit competitively the nigral dopamine sensitive 
adenylate cyclase. The dopamine sensitive adenylate 
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cyclase was observed to be more concentrated in the 
pars reticulata (a region of the substantia nigra rich 
in dendrites from the dopamine neurones) than 
in the pars compacta which mainly contains the cell 
bodies of these neurones [ 151 and therefore the dop- 
aminergic autoreceptors. In order to check the 
possibility that the dopamine sensitive adenylate 
cyclase could be coupled with autoreceptors localized 
on the dopaminergic neurones, we had specifically 
destroyed these neurones by a local injection of 
6-hydroxydopamine (6-OH-DA). However, after this 
lesion, the dopamine-sensitive adenylate cyclase was 
still present. In contrast, after an hemisection of the 
brain, the dopamine sensitive adenylate cyclase of 
the substantia nigra completely disappeared. 
These findings can support the hypothesis that the 
dopamine sensitive adenylate cyclase in the substantia 
nigra is not coupled with the dopamine autoreceptors. 
It is proposed that the dopamine sensitive adenylate 
cyclase described in this report, could be localized on 
the terminals of the gabaminergic neurones originat- 
ing within the striatum and/or from the globus pallidus 
[16,17] and projecting into the substantia nigra. 
2. Methods 
Male Charles River rats (weighing about 350-450 g) 
were sacrified by decapitation. The caudal part of 
their brains was fixed on a Leitz Westler microtome 
stage refrigerated at -7°C and slices (thickness 500 pm) 
were made. Substantia nigra, dissected with a micro- 
scalpel, were homogeneized with a teflon Potter- 
Elrehjem in 2 mM Tris-Maleate pH 7.2,2 mM EGTA 
pH 7.2,300 mM sucrose. Preparation of striatal 
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homogenates and the conditions of the adenylate 
cyclase assay have been previously described [6]. The 
DA content in the SN homogenates was determined 
using a radioenzymatic assay [ 181. DA neurones were 
destroyed by injecting 1 /.d of an isotonic saline solu- 
tion containing 6 OH-DA (2 pg), ascorbic acid (2 mg/ 
ml) adjusted at pH 5 into the rostral and the caudal 
parts of the SN (A: 2580 pm and A: 1760 pm, res- 
pectively according to the atlas of Kiinig and Klippel 
[ 191). The hemisections were done at the level of the 
plane A: 4380 pm [ 191. 
3. Results and discussion 
3.1. Some pharmacological properties of the sub- 
stantra nigra DA sensitive adenylate cyclase 
DA and NE stimulated markedly the basal 
adenylate cyclase of the SN. Their effects were not 
additive; this suggests that these catecholamines inter- 
act with the same receptor (fig.1). As observed in the 
striatum [ 1 ] , apomorphine (1 0W4 M) was less 
effective. D-LSD previously shown to be a partial 
agonist of the striatal [6,20-221 and cerebral cortex 
[22] DA sensitive adenylate cyclases, was found to 
exhibit a poor agonist effect whereas it had a very 
strong antagonist effect on the SN dopamine sensitive 
adenylate cyclase (tig.1). 
The specificity of the nigral DA sensitive adenylate 
cyclase towards dopaminergic agonists is therefore 
identical to that described for the postsynaptic 
striatal DA sensitive adenylate cyclase [l-6] . Iso- 
proterenol, a pure /3 agonist was without effect on the 
basal adenylate cyclase activity (ftg.1). This appears to 
be in contrast with that observed in rat striatum [6] 
and frontal cerebral cortex [23]. Serotonine (5-HT) 
was also ineffective on the nigral adenylate cyclase 
(fig.1). 
3.2. Relative affinities of the n&al and striatal DA 
sensitive adenylate cyclases for dopamine, norepine- 
phrine and neuroleptics 
The apparent affinity of the nigral dopaminergic 
receptor for DA was about 2-fold lower than that of 
the striatal dopaminergic receptor. (Kd = 9.5 + 0.23 PM, 
N = 5 and 3.9 + 0.39 PM, N = 5 respectively). The 
difference between the relative apparent affinities of 
these two receptors for NE was even higher (I& = 175 
*2.5pM,N=3inSNand42.5+2.5pM,N=3in 
striatum). Thus, in these two structures NE was 10 to 
20 times less potent than DA, suggesting that DA is 
the physiological agonist. Haloperidol a high potent 
neuroleptic inhibited in a competitive manner the 
nigral and striatal DA sensitive adenylate cyclases 
(fig.2). 
The apparent affinity for haloperidol of the SN 
dopaminergic receptor was two times lower than that 
of the striatal DA receptor (Ki = 108 + 2.7 nM, 
IS0 5-HT z-44 IS0 APO LSD L%& DA 
*DA *NE 
Fig.1. Some pharmacological properties of the SN dopamine sensitive adenylate cyclase. Drugs were tested at the following con- 
centrations: dopamine (DA; 5 X lo-’ M), L-norepinephrine (NE; 5 X 10m4 M), L-isoproterenol (ISO; 5 X lo-’ M), serotonine 
(5 HT; 5 X lo-’ M), apomorphine (APO; lo-’ M) and D-LSD (LSD; lo-’ M). B = basal activity in the absence of drug. Each value 
is the mean f SEM of three determinations. 
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Fig.2. Competitive inhibition of SN and striatal dopamine sensitive adenylate cyclases by haloperidol. The left part represents the 
dose response curves for the DA sensitive adenylate cyclases of the SN and of the striatum made in the absence (0) or presence (A) 
of haloperidol (5 X lo-’ M). The right part represents the Hofstee plot of the dose response curves. The value of respective 
apparent KD and KI calculated from this plot are indicated on the figure. V = adenylate cyclase activity in presence of DA alone 
or DA + haloperidol; C = basal adenylate cyclase activity; S = DA concentration. 
N = 3 in the SN and 62.7 f. 2.6 nM, N = 3 in the 
striatum). 
The relative potency of various neuroleptics to 
antagonize the nigral DA sensitive adenylate cyclase 
was comparable to that observed for the striatal DA 
sensitive adenylate cyclase (table 1) [23]. 
Table 1 
Effect of different neuroleptics on basal, and DA sensitive 
adenylate cyclase activities 
Neuroleptic Adenylate cyclase activities 
Basal + DA (lo-’ M) 
Increase of cyclic AMP 
production of presence 
of DA (% of control) 
Control 62.9 122.6 100 
(Y Flupenthixol 58.2 61.2 4.0 
Fluphenazine 58.3 64.5 9.5 
Haloperidol 59.4 70.8 19.0 
Chlorpromazine 58.3 77.8 33.0 
Thioridazine 59.1 84.0 43.0 
Clozapine 58.2 84.4 44.0 
Thioproperazine 56.6 95.4 65.0 
The increase of cyclic AMP produced in the presence of DA are expressed in % of 
the control value in absence or neuroleptic. Each value is the mean of two 
independent determinations which were within less than 10% of a mean determina- 
tion. 
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3.3. The nigral DA sensitive adenylate cyclase is not 
localized on dopaminergic cell bodies 
The DA sensitive adenylate cyclase was determined 
in homogenates of the pars reticulata and of the pars 
compacta. The increase in cyclic AMP induced by DA 
(10M4 M) was about 2.5-fold higher in the pars reticu- 
lata which is rich in dopaminergic cell deutrites, than 
in the pars compacta where the dopaminergic cell 
bodies are mainly concentrated (table 2). Three weeks 
after the unilateral injection of 6-OH-DA into the SN, 
most of neurones had degenerated as indicated by the 
marked decrease in the nigral DA content (85%) 
(table 3). However, the cyclic AMP production of the 
SN devoid of the DA cell bodies remained identical to 
that observed in the contralateral side or in nigral 
homogenates of control rats (table 3). 
These results suggested that the DA sensitive 
adenylate cyclase was not coupled with the DA auto- 
receptors. This conclusion is further supported by the 
absence of a DA sensitive adenylate cyclase in the Are 
area (Bockaert et al., umpublished data) which contains 
most of the cell bodies of the mesocortical [24-261 
and mesolimbic [27] dopaminergic neurones. 
The unilateral hemisection of the brain made 
between the SN and the striatum led to the complete 
disappearance of the ipsilateral nigral DA sensitive 
adenylate cyclase but did not affect the DA sensitive 
adenylate cyclase of the contralateral SN (table 4). 
This may indicate that this DA sensitive adenylate 
cyclase is not localized on interneurones in the SN. 
It could be associated to terminals of neurones 
originating rostrally to the SN. It is tempting to 
Table 2 
Repartition of the DA sensitive adenylate cyclase between the pars 
compacta and the pars reticulata of the SN 
Adenylate cyclase activities 
(pmol/3 min/mg protein) 
_ 
Pars compacta Pars reticulata 
Exp. No. Basal + DA (lo-’ M) a Basal + DA (lo-’ M) a 
1 78.8 130.6 51.8 60.8 152.6 91.6 
2 99.2 132.6 33.4 197.0 299.8 102.8 
A = Cyclic AMP production due to the presence of DA. Each value is the mean of two 
independent determinations which were within less than 10% of a mean determination. 
Table 3 
Effect of the destruction of dopaminergic cell bodies of SN on the 
DA sensitive adenylate cyclase activity 
Increase of cyclic AMP Dopamine content 
in presence of DA (10m4 M) (pg/mg protein) 
(pmol/6 min/mg protein) 
Ipsilateral 
(6-OH-DA lesioned) 170.5 ?: 15.3 (N = 4) 942 * 292 (N = 4) 
Contralateral 171.3 + 24.5 (N = 4) 6334 * 466 (N = 4) 
Control 159.7 + 15 (N = 6) 8184k718 (N = 4) 
Three weeks after the local unilateral injection of 6-OH-DA, the ipsilateral and 
contralateral SN of the lesioned rats and SN of control rats were dissected and 
homogeneized in 100 ~1 of the homogeneization medium. DA was estimated in 
50 pl aliquot aud 50 ~1 were used for measuring the DA sensitive adenylate 
cyclase. The basal adenylate cyclase activity did not change after lesions. The 
values are the mean + SEM of the results obtained with 4 or 6 animals. 
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Table 4 
Effect of unilateral brain hemisection on the DA 
sensitive adenylate cyclase of SN 
Adenylate cyclase activities 
(pmol/3 min/mg protein) 
Basal + DA (lo-’ M) 
Ipsilateral 
(hemisectioned) 
Contralateral 
Control 
90.9 * 0.3 (N = 3) 87.8 + 13 (N = 3) 
92.3 i 11.3 (N = 3) 163.7 + 12 (N = 3) 
106 * 6.6 (N=4) 183.7 + 11.3 (N = 4) 
Four weeks after the unilateral hemisection, the ipsilateral and contralateral SN 
of lesioned rat and SN of control animals were dissected and homogenized 
individually in 60 ~1. The values are the mean f SEM of the results obtained with 
3 or 4 animals. 
propose that the DA sensitive adenylate cyclase in the 
SN is located on terminals of the gabaminergic neurones 
which control the activity of the dopaminergic 
neurones (for review see [ 171). 
There is increasing evidence that dopamine may be 
released from dentrites of the dopaminergic neurones 
in the SN [28,29] . The DA sensitive adenylate cyclase 
described in this report associated to DA receptors not 
located on dopaminergic neurones might correspond 
to one of the sites of action for dopamine released 
from the dopaminergic dentrites. 
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